While these biomarkers may not be relevant for all bladder cancer patients, elevated levels of β-hCG and CA125 in certain individuals can indicate potential metastatic disease or early progression of cancer that may not be detected through other diagnostic tests. The gene discussed is MUC16; the disease is urinary bladder carcinoma.